"Bloodless" treatment of a Jehovah's Witness infant with ABO hemolytic disease

Journal of Perinatology

Volumn 19, Issue 7, 1999, Pages 530-532

  Lakatos, Lajos ^a   Csáthy, Lászlo ^a   Nemes, Eva ^a  

^a Kenezy Korhaz Rendelointezet   (Hungary)

Author keywords

[No Author keywords available]

Indexed keywords

ERYTHROPOIETIN; PENICILLAMINE; RECOMBINANT PROTEIN;

ARTICLE; BLOOD; BLOOD GROUP ABO SYSTEM; CASE REPORT; FEMALE; FLUID THERAPY; HUMAN; NEWBORN; NEWBORN HEMOLYTIC DISEASE; PHOTOTHERAPY; RELIGION; TREATMENT OUTCOME;

ABO BLOOD-GROUP SYSTEM; CHRISTIANITY; ERYTHROBLASTOSIS, FETAL; ERYTHROPOIETIN; FEMALE; FLUID THERAPY; HUMANS; INFANT, NEWBORN; PENICILLAMINE; PHOTOTHERAPY; RECOMBINANT PROTEINS; TREATMENT OUTCOME;

EID: 0033202314     PISSN: 07438346     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.jp.7200223     Document Type: Review

References (25)

1. Cashore WJ, Stern L. The jaundiced newborn. In: Warshaw JB, Hobbins JC, editors. Principles and Practice of Perinatal Medicine Maternal-Fetal and Newborn Care. Menlo Park, CA: Addison-Wesley Publishing Company; 1983. p. 342-62.
2. Lakatos L, Kövér B, Péter F. D-penicillamine therapy of neonatal hyperbilirubinaemia. Acta Paediatr Acad Sci Hung 1974;15:77-85.
3. Brodersen R, Lakatos L, Karmazsin L D-penicillamine, a non-bilirubin-displacing drug in neonatal jaundice. Acta Paediatr Scand 1980;69:31-5.
4. Lakatos L, Kövér B, Oroszlán Gy, Vekerdy ZS. D-penicillamine therapy in ABO hemolytic disease of the newborn infant. Eur J Pediatr 1976;123:133-7.
5. Korányi GY, Kovács J, Vörös I. D-penicillamine treatment of hyperbilirubinaemia in preterm infants. Acta Paediatr Acad Sci Hung 1978;19:9-16.
6. Lakatos L, Lakatos ZS, Hatvani I, et al. Controlled trial of use of D-penicillamine to prevent retinopathy of prematurity in very low-birth-weight infants. In: Stern L, Oh W, Friis-Hansen B, editors. Physiologic Foundations of Perinatal Care, Volume 2. Amsterdam: Elsevier; 1987. p. 9-24.
7. Phelps DL, Lakatos L, Watts JL. D-penicillamine to prevent retinopathy of prematurity (Cochrane review). In: Cochrane Library, Issue 2. Oxford: Update Software; 1998. Updated quarterly.
8. Rangachari PK, Kean WF. Gold and D-penicillamine and the gastrointestinal tract. Baillières Clin Rheumatol 1989;3:411-23.
9. Frankel LS, Damme CJ, Van EysJ. Childhood cancer and the Jehovah's Witness faith. Pediatrics 1977;60:916-21.
10. Johnson CP, Blasco PA. Infant growth and development. Pediatr Rev 1997; 18: 224-44.
11. Newman TB, Maisels MJ. Evaluation and treatment of jaundice in the term newborn: a kinder, gentler approach. Pediatrics 1992;89:809-18.
12. Lakatos L D-penicillamine and retinopathy of prematurity. Pediatrics 1988;82: 951-2.
13. Lakatos L, Oroszlan GY. Possible effect of D-penicillamine on the physiologic action of inhaled nitric oxide in neonates. J Pediatr 1994;123:656-7.
14. Malcontent (Silverman WA). Fumes from the spleen. Paediatr Perinat Epidemiol 1996;10:406-9.
15. Drosos AA, Geogriou P, Politi EN, Voulgari PV. D-penicillamine in early rheumatoid arthritis. Clin Exp Rheumatol 1997;15:580-1.
16. Rosa FW. Teratogen update: penicillamine. Teratology 1986;33:127-31.
17. Chowrimootoo GFE, Scowcroft H, Seymour CA. Ceruloplasmin isoforms in Wilson's disease in neonates. Arch Dis Child Fetal Neonatal Ed 1998;79:F198-F201.
18. Oroszlan GY, Lakatos L, Szabo L, et al. Heme oxygenase activity is decreased by D-penicillamine in neonates. Experientia 1983;39:888-9.
19. SanderudJ, Oroszlan GY, Bjoro K, et al. D-penicillamine inhibits the action of reactive oxygen species in the pig pulmonary circulation. J Perinat Med 1995;23: 103-16.
20. Staite ND, Zoschke DC, Messner RP. Scavenging of hydrogen peroxide - a new mechanism of action for D-penicillamine in rheumatoid arthritis? N Engl J Med 1984;311:538-9.
21. Betts WH, Cleland LG, Gee DJ, Whitehouse MW. Effects of D-penicillamine on a model of oxygen-derived free radical-mediated tissue damage. Agents Actions 1984;14:283-90.
22. Yeo KL, Perlman M, Hao Y, Mullaney P. Outcomes of extremely premature infants related to their peak serum bilirubin concentrations and exposure to phototherapy. Pediatrics 1998;102:1426-31.
23. Williamson P, Griffiths G, Norfolk D, Levene M. Blood transfusions and human recombinant erythropoietin in premature newborn infants. Arch Dis Child Fetal Neonatal Ed 1996;75:F65-F68.
24. Chen JY, Wu TS, Chanlai SP. Recombinant human erythropoietin in the treatment of anemia of prematurity. Am J Perinatol 1995;12:314-8.
25. Ovali F, Samanci N, Dagoglu T. Management of late anemia in rhesus hemolytic disease: use of recombinant human erythropoietin (a pilot study). Pediatr Res 1996;39:831-4.